Articles by James A. Simon, MD

1 2 3 4 5

The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal...

Constantine, Ginger D.; Simon, James A.; Pickar, James H.; More

Menopause. 24(4):409-416, April 2017.

Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture

Simon, James A.; Recknor, Christopher; Moffett, Alfred H. Jr; More

Menopause. 20(2):130-137, February 2013.

  • Editorial

Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density

Bachmann, Gloria; Kriegman, Audrey; Gonçalves, Joana; More

Menopause. 18(8):851-856, August 2011.

  • Editorial

Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in luteinizing hormone and follicle-stimulating hormone with age

Ferrell, Rebecca J.; O'Connor, Kathleen A.; Holman, Darryl J.; More

Menopause. 14(1):29-37, January-February 2007.

Lifelong menstrual histories are typically erratic and trending: a taxonomy

Gorrindo, Tristan; Lu, Ying; Pincus, Steve; More

Menopause. 14(1):74-88, January-February 2007.

Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms

Simon, James A.; for the ESTRASORB Study Group

Menopause. 13(2):222-231, March-April 2006.

A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms

Botteman, Marc F.; Shah, Nisha P.; Lian, Jean; More

Menopause. 11(3):343-355, May-June 2004.

1 2 3 4 5